Nouvelles Pharma

FDA
The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a [...]
Fri, May 18, 2018
Source Pharma News
The skyrocketing cost of prescription drugs is one of the biggest concerns for American voters. However, in his proposal last Friday, President Donald Trump failed to offer any new policies that would expand access, reduce costs, or increase the safety and efficacy of prescriptions. Today, a group of 21 prominent [...]
Thu, May 17, 2018
Source Pharma News
SMi Group
10 - 11 October, London, UK. SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October. Cell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and [...]
Thu, May 17, 2018
Source Pharma News
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. [...]
Wed, May 16, 2018
Source Pharma News

(de Worldpharmanews)

Contactez nous
Dispopharm D&P Ltd.
Gewerbestrasse 18
4123 Allschwil
Suisse
Téléphone: +41 61 487 96 36
Fax. +41 61 487 96 20
dispopharm@dispopharm.com
Dates
No dates at the moment.